Physician

Joseph Edward Fruland, MD

According to 2025 Medicare claims, Joseph Fruland, MD (NPI: 1952357337) practices dermatology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is ARNETT CLINIC, LLC (NPI: 1164490843; TIN: 352030653) and primary practice location at 47904-3055. Fruland is affiliated with the Indiana University Health ACO, Inc. (ACO ID: D0034), participating under the REACH model.

Fruland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 811 traditional Medicare patients, billed 4,496 HCPCS/CPT codes, and received $193,143 in Medicare payments. The top billing code was 11104 (Punch biopsy, first skin growth). Part D data shows 544 prescription claims across 256 beneficiaries totaling $121,333 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$124K$248K2015 Medicare payment: $247,586 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $241,959 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $245,705 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $234,177 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $248,404 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $202,267 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $220,494 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $194,053 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $189,090 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $193,143 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1826,482$247,586
20161,2426,593$241,959
20171,2316,932$245,705
20181,1936,568$234,177
20191,1766,290$248,404
20201,0335,317$202,267
20219755,175$220,494
20229014,706$194,053
20238344,556$189,090
20248114,496$193,143

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$213K$427K2015 Drug cost: $222,126 (USD; Tot_Drug_Cst)2016 Drug cost: $256,081 (USD; Tot_Drug_Cst)2017 Drug cost: $281,636 (USD; Tot_Drug_Cst)2018 Drug cost: $397,845 (USD; Tot_Drug_Cst)2019 Drug cost: $367,185 (USD; Tot_Drug_Cst)2020 Drug cost: $366,103 (USD; Tot_Drug_Cst)2021 Drug cost: $426,965 (USD; Tot_Drug_Cst)2022 Drug cost: $276,108 (USD; Tot_Drug_Cst)2023 Drug cost: $264,146 (USD; Tot_Drug_Cst)2024 Drug cost: $121,333 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015315649$222,126
2016290628$256,081
2017284614$281,636
2018306710$397,845
2019291661$367,185
2020282653$366,103
2021275636$426,965
2022250561$276,108
2023230519$264,146
2024256544$121,333

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11104Punch biopsy, first skin growth353491$80
17110Destruction of skin growth, 1-14 growths218272$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7491,126$59
17000Destruction of precancer skin growth, 1 growth382632$34
17003Destruction of precancer skin growth, 2-14 growths2591,237$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil30756$2,062
MetronidazoleMetronidazole26745$1,366
KetoconazoleKetoconazole822,446$1,098
Doxycycline HyclateDoxycycline Hyclate34928$957
Clindamycin PhosphateClindamycin Phosphate24944$917

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$25ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joseph Edward Fruland, MD?

Tedicare shows public-source Medicare data for Joseph Edward Fruland, MD (NPI 1952357337), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Edward Fruland, MD have ACO affiliation data?

Joseph Edward Fruland, MD is shown with ACO affiliation data for Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Joseph Edward Fruland, MD?

Joseph Edward Fruland, MD is linked to ARNETT CLINIC, LLC (billing NPI 1164490843) in the available physician profile data.

Does Joseph Edward Fruland, MD have Open Payments data?

Joseph Edward Fruland, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.